0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dementia Diagnosis Solutions Market Research Report 2026
Published Date: 2026-03-16
|
Report Code: QYRE-Auto-27Z17274
Home | Market Reports | Health| Aging & Geriatrics
Global Dementia Diagnosis Solutions Market Research Report 2024
BUY CHAPTERS

Global Dementia Diagnosis Solutions Market Research Report 2026

Code: QYRE-Auto-27Z17274
Report
2026-03-16
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dementia Diagnosis Solutions Market

The global Dementia Diagnosis Solutions market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Dementia Diagnosis Solutions refers to the various methods, tools, and technologies used to diagnose dementia, a group of symptoms affecting memory, thinking, and social abilities severely enough to interfere with daily life. These solutions aim to identify the type and stage of dementia to provide appropriate treatment and care.
The North American market for Dementia Diagnosis Solutions is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Dementia Diagnosis Solutions is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Dementia Diagnosis Solutions in Medical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Dementia Diagnosis Solutions include Johnson & Johnson, Corium, Roche, Quanterix, Eli Lilly & Company, Novartis, Allergan, C₂N Diagnostics, Combinostics, Cognoptix, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Dementia Diagnosis Solutions market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dementia Diagnosis Solutions. The Dementia Diagnosis Solutions market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dementia Diagnosis Solutions market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dementia Diagnosis Solutions manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Dementia Diagnosis Solutions Market Report

Report Metric Details
Report Name Dementia Diagnosis Solutions Market
Segment by Type
  • Traditional Diagnostic Technology
  • Bioinformatics Diagnostic Technology
  • Others
Segment by Application
  • Medical
  • Community
  • Family
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Corium, Roche, Quanterix, Eli Lilly & Company, Novartis, Allergan, C₂N Diagnostics, Combinostics, Cognoptix, GT Diagnostics, Quest Diagnostics, DiADeM (Diagnosing Advanced Dementia Mandate)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Dementia Diagnosis Solutions companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Dementia Diagnosis Solutions Market report?

Ans: The main players in the Dementia Diagnosis Solutions Market are Johnson & Johnson, Corium, Roche, Quanterix, Eli Lilly & Company, Novartis, Allergan, C₂N Diagnostics, Combinostics, Cognoptix, GT Diagnostics, Quest Diagnostics, DiADeM (Diagnosing Advanced Dementia Mandate)

What are the Application segmentation covered in the Dementia Diagnosis Solutions Market report?

Ans: The Applications covered in the Dementia Diagnosis Solutions Market report are Medical, Community, Family

What are the Type segmentation covered in the Dementia Diagnosis Solutions Market report?

Ans: The Types covered in the Dementia Diagnosis Solutions Market report are Traditional Diagnostic Technology, Bioinformatics Diagnostic Technology, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia Diagnosis Solutions Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Traditional Diagnostic Technology
1.2.3 Bioinformatics Diagnostic Technology
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dementia Diagnosis Solutions Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical
1.3.3 Community
1.3.4 Family
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dementia Diagnosis Solutions Market Perspective (2021–2032)
2.2 Global Dementia Diagnosis Solutions Growth Trends by Region
2.2.1 Global Dementia Diagnosis Solutions Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Dementia Diagnosis Solutions Historic Market Size by Region (2021–2026)
2.2.3 Dementia Diagnosis Solutions Forecasted Market Size by Region (2027–2032)
2.3 Dementia Diagnosis Solutions Market Dynamics
2.3.1 Dementia Diagnosis Solutions Industry Trends
2.3.2 Dementia Diagnosis Solutions Market Drivers
2.3.3 Dementia Diagnosis Solutions Market Challenges
2.3.4 Dementia Diagnosis Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dementia Diagnosis Solutions Players by Revenue
3.1.1 Global Top Dementia Diagnosis Solutions Players by Revenue (2021–2026)
3.1.2 Global Dementia Diagnosis Solutions Revenue Market Share by Players (2021–2026)
3.2 Global Top Dementia Diagnosis Solutions Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Dementia Diagnosis Solutions Revenue
3.4 Global Dementia Diagnosis Solutions Market Concentration Ratio
3.4.1 Global Dementia Diagnosis Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia Diagnosis Solutions Revenue in 2025
3.5 Global Key Players of Dementia Diagnosis Solutions Head Offices and Areas Served
3.6 Global Key Players of Dementia Diagnosis Solutions, Products and Applications
3.7 Global Key Players of Dementia Diagnosis Solutions, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Dementia Diagnosis Solutions Breakdown Data by Type
4.1 Global Dementia Diagnosis Solutions Historic Market Size by Type (2021–2026)
4.2 Global Dementia Diagnosis Solutions Forecasted Market Size by Type (2027–2032)
5 Dementia Diagnosis Solutions Breakdown Data by Application
5.1 Global Dementia Diagnosis Solutions Historic Market Size by Application (2021–2026)
5.2 Global Dementia Diagnosis Solutions Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Dementia Diagnosis Solutions Market Size (2021–2032)
6.2 North America Dementia Diagnosis Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Dementia Diagnosis Solutions Market Size by Country (2021–2026)
6.4 North America Dementia Diagnosis Solutions Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dementia Diagnosis Solutions Market Size (2021–2032)
7.2 Europe Dementia Diagnosis Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Dementia Diagnosis Solutions Market Size by Country (2021–2026)
7.4 Europe Dementia Diagnosis Solutions Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dementia Diagnosis Solutions Market Size (2021–2032)
8.2 Asia-Pacific Dementia Diagnosis Solutions Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Dementia Diagnosis Solutions Market Size by Region (2021–2026)
8.4 Asia-Pacific Dementia Diagnosis Solutions Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dementia Diagnosis Solutions Market Size (2021–2032)
9.2 Latin America Dementia Diagnosis Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Dementia Diagnosis Solutions Market Size by Country (2021–2026)
9.4 Latin America Dementia Diagnosis Solutions Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dementia Diagnosis Solutions Market Size (2021–2032)
10.2 Middle East & Africa Dementia Diagnosis Solutions Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Dementia Diagnosis Solutions Market Size by Country (2021–2026)
10.4 Middle East & Africa Dementia Diagnosis Solutions Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Dementia Diagnosis Solutions Introduction
11.1.4 Johnson & Johnson Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.1.5 Johnson & Johnson Recent Development
11.2 Corium
11.2.1 Corium Company Details
11.2.2 Corium Business Overview
11.2.3 Corium Dementia Diagnosis Solutions Introduction
11.2.4 Corium Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.2.5 Corium Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Dementia Diagnosis Solutions Introduction
11.3.4 Roche Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Quanterix
11.4.1 Quanterix Company Details
11.4.2 Quanterix Business Overview
11.4.3 Quanterix Dementia Diagnosis Solutions Introduction
11.4.4 Quanterix Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.4.5 Quanterix Recent Development
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Details
11.5.2 Eli Lilly & Company Business Overview
11.5.3 Eli Lilly & Company Dementia Diagnosis Solutions Introduction
11.5.4 Eli Lilly & Company Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.5.5 Eli Lilly & Company Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Dementia Diagnosis Solutions Introduction
11.6.4 Novartis Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.6.5 Novartis Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Dementia Diagnosis Solutions Introduction
11.7.4 Allergan Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.7.5 Allergan Recent Development
11.8 C₂N Diagnostics
11.8.1 C₂N Diagnostics Company Details
11.8.2 C₂N Diagnostics Business Overview
11.8.3 C₂N Diagnostics Dementia Diagnosis Solutions Introduction
11.8.4 C₂N Diagnostics Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.8.5 C₂N Diagnostics Recent Development
11.9 Combinostics
11.9.1 Combinostics Company Details
11.9.2 Combinostics Business Overview
11.9.3 Combinostics Dementia Diagnosis Solutions Introduction
11.9.4 Combinostics Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.9.5 Combinostics Recent Development
11.10 Cognoptix
11.10.1 Cognoptix Company Details
11.10.2 Cognoptix Business Overview
11.10.3 Cognoptix Dementia Diagnosis Solutions Introduction
11.10.4 Cognoptix Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.10.5 Cognoptix Recent Development
11.11 GT Diagnostics
11.11.1 GT Diagnostics Company Details
11.11.2 GT Diagnostics Business Overview
11.11.3 GT Diagnostics Dementia Diagnosis Solutions Introduction
11.11.4 GT Diagnostics Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.11.5 GT Diagnostics Recent Development
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Details
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Dementia Diagnosis Solutions Introduction
11.12.4 Quest Diagnostics Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.12.5 Quest Diagnostics Recent Development
11.13 DiADeM (Diagnosing Advanced Dementia Mandate)
11.13.1 DiADeM (Diagnosing Advanced Dementia Mandate) Company Details
11.13.2 DiADeM (Diagnosing Advanced Dementia Mandate) Business Overview
11.13.3 DiADeM (Diagnosing Advanced Dementia Mandate) Dementia Diagnosis Solutions Introduction
11.13.4 DiADeM (Diagnosing Advanced Dementia Mandate) Revenue in Dementia Diagnosis Solutions Business (2021–2026)
11.13.5 DiADeM (Diagnosing Advanced Dementia Mandate) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Dementia Diagnosis Solutions Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Traditional Diagnostic Technology
 Table 3. Key Players of Bioinformatics Diagnostic Technology
 Table 4. Key Players of Others
 Table 5. Global Dementia Diagnosis Solutions Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Dementia Diagnosis Solutions Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Dementia Diagnosis Solutions Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Dementia Diagnosis Solutions Market Share by Region (2021–2026)
 Table 9. Global Dementia Diagnosis Solutions Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Dementia Diagnosis Solutions Market Share by Region (2027–2032)
 Table 11. Dementia Diagnosis Solutions Market Trends
 Table 12. Dementia Diagnosis Solutions Market Drivers
 Table 13. Dementia Diagnosis Solutions Market Challenges
 Table 14. Dementia Diagnosis Solutions Market Restraints
 Table 15. Global Dementia Diagnosis Solutions Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Dementia Diagnosis Solutions Market Share by Players (2021–2026)
 Table 17. Global Top Dementia Diagnosis Solutions Players by Tier (Tier 1, Tier 2, and Tier 3), based on Dementia Diagnosis Solutions Revenue, 2025
 Table 18. Ranking of Global Top Dementia Diagnosis Solutions Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Dementia Diagnosis Solutions Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Dementia Diagnosis Solutions, Headquarters and Area Served
 Table 21. Global Key Players of Dementia Diagnosis Solutions, Products and Applications
 Table 22. Global Key Players of Dementia Diagnosis Solutions, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Dementia Diagnosis Solutions Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Dementia Diagnosis Solutions Revenue Market Share by Type (2021–2026)
 Table 26. Global Dementia Diagnosis Solutions Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Dementia Diagnosis Solutions Revenue Market Share by Type (2027–2032)
 Table 28. Global Dementia Diagnosis Solutions Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Dementia Diagnosis Solutions Revenue Market Share by Application (2021–2026)
 Table 30. Global Dementia Diagnosis Solutions Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Dementia Diagnosis Solutions Revenue Market Share by Application (2027–2032)
 Table 32. North America Dementia Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Dementia Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Dementia Diagnosis Solutions Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Dementia Diagnosis Solutions Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Dementia Diagnosis Solutions Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Dementia Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Dementia Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Dementia Diagnosis Solutions Market Size by Country (US$ Million), 2027–2032
 Table 47. Johnson & Johnson Company Details
 Table 48. Johnson & Johnson Business Overview
 Table 49. Johnson & Johnson Dementia Diagnosis Solutions Product
 Table 50. Johnson & Johnson Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 51. Johnson & Johnson Recent Development
 Table 52. Corium Company Details
 Table 53. Corium Business Overview
 Table 54. Corium Dementia Diagnosis Solutions Product
 Table 55. Corium Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 56. Corium Recent Development
 Table 57. Roche Company Details
 Table 58. Roche Business Overview
 Table 59. Roche Dementia Diagnosis Solutions Product
 Table 60. Roche Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 61. Roche Recent Development
 Table 62. Quanterix Company Details
 Table 63. Quanterix Business Overview
 Table 64. Quanterix Dementia Diagnosis Solutions Product
 Table 65. Quanterix Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 66. Quanterix Recent Development
 Table 67. Eli Lilly & Company Company Details
 Table 68. Eli Lilly & Company Business Overview
 Table 69. Eli Lilly & Company Dementia Diagnosis Solutions Product
 Table 70. Eli Lilly & Company Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 71. Eli Lilly & Company Recent Development
 Table 72. Novartis Company Details
 Table 73. Novartis Business Overview
 Table 74. Novartis Dementia Diagnosis Solutions Product
 Table 75. Novartis Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 76. Novartis Recent Development
 Table 77. Allergan Company Details
 Table 78. Allergan Business Overview
 Table 79. Allergan Dementia Diagnosis Solutions Product
 Table 80. Allergan Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 81. Allergan Recent Development
 Table 82. C₂N Diagnostics Company Details
 Table 83. C₂N Diagnostics Business Overview
 Table 84. C₂N Diagnostics Dementia Diagnosis Solutions Product
 Table 85. C₂N Diagnostics Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 86. C₂N Diagnostics Recent Development
 Table 87. Combinostics Company Details
 Table 88. Combinostics Business Overview
 Table 89. Combinostics Dementia Diagnosis Solutions Product
 Table 90. Combinostics Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 91. Combinostics Recent Development
 Table 92. Cognoptix Company Details
 Table 93. Cognoptix Business Overview
 Table 94. Cognoptix Dementia Diagnosis Solutions Product
 Table 95. Cognoptix Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 96. Cognoptix Recent Development
 Table 97. GT Diagnostics Company Details
 Table 98. GT Diagnostics Business Overview
 Table 99. GT Diagnostics Dementia Diagnosis Solutions Product
 Table 100. GT Diagnostics Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 101. GT Diagnostics Recent Development
 Table 102. Quest Diagnostics Company Details
 Table 103. Quest Diagnostics Business Overview
 Table 104. Quest Diagnostics Dementia Diagnosis Solutions Product
 Table 105. Quest Diagnostics Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 106. Quest Diagnostics Recent Development
 Table 107. DiADeM (Diagnosing Advanced Dementia Mandate) Company Details
 Table 108. DiADeM (Diagnosing Advanced Dementia Mandate) Business Overview
 Table 109. DiADeM (Diagnosing Advanced Dementia Mandate) Dementia Diagnosis Solutions Product
 Table 110. DiADeM (Diagnosing Advanced Dementia Mandate) Revenue in Dementia Diagnosis Solutions Business (US$ Million), 2021–2026
 Table 111. DiADeM (Diagnosing Advanced Dementia Mandate) Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Dementia Diagnosis Solutions Picture
 Figure 2. Global Dementia Diagnosis Solutions Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Dementia Diagnosis Solutions Market Share by Type: 2025 vs 2032
 Figure 4. Traditional Diagnostic Technology Features
 Figure 5. Bioinformatics Diagnostic Technology Features
 Figure 6. Others Features
 Figure 7. Global Dementia Diagnosis Solutions Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Dementia Diagnosis Solutions Market Share by Application: 2025 vs 2032
 Figure 9. Medical Case Studies
 Figure 10. Community Case Studies
 Figure 11. Family Case Studies
 Figure 12. Dementia Diagnosis Solutions Report Years Considered
 Figure 13. Global Dementia Diagnosis Solutions Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Dementia Diagnosis Solutions Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Dementia Diagnosis Solutions Market Share by Region: 2025 vs 2032
 Figure 16. Global Dementia Diagnosis Solutions Market Share by Players in 2025
 Figure 17. Global Dementia Diagnosis Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Dementia Diagnosis Solutions Revenue in 2025
 Figure 19. North America Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Dementia Diagnosis Solutions Market Share by Country (2021–2032)
 Figure 21. United States Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Dementia Diagnosis Solutions Market Share by Country (2021–2032)
 Figure 25. Germany Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Dementia Diagnosis Solutions Market Share by Region (2021–2032)
 Figure 33. China Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Dementia Diagnosis Solutions Market Share by Country (2021–2032)
 Figure 41. Mexico Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Dementia Diagnosis Solutions Market Share by Country (2021–2032)
 Figure 45. Israel Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Dementia Diagnosis Solutions Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Johnson & Johnson Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 49. Corium Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 50. Roche Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 51. Quanterix Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 52. Eli Lilly & Company Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 53. Novartis Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 54. Allergan Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 55. C₂N Diagnostics Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 56. Combinostics Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 57. Cognoptix Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 58. GT Diagnostics Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 59. Quest Diagnostics Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 60. DiADeM (Diagnosing Advanced Dementia Mandate) Revenue Growth Rate in Dementia Diagnosis Solutions Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS